Early detection of heart decompensation by intrathoracic impedance monitoring by means of the OptiVol Patient Alert(TM) in Medtronic(R) InSync Sentry(TM) ICDs
Completed
- Conditions
- heart failure10019280
- Registration Number
- NL-OMON30764
- Lead Sponsor
- Catharina-ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
chronic heartfailure of any cause
implantation of Medtronic(R) InSync Sentry(TM) ICD
Exclusion Criteria
impossibility to give informed-consent
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>number of true positive OptiVol (TM) alarms</p><br>
- Secondary Outcome Measures
Name Time Method <p>not applicable</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie intrathoracic impedance changes in heart failure patients using OptiVol Patient Alert(TM)?
How does OptiVol Patient Alert(TM) compare to standard-of-care in early heart failure decompensation detection?
Which biomarkers correlate with OptiVol Patient Alert(TM) sensitivity in predicting heart failure exacerbations?
What adverse events are associated with intrathoracic impedance monitoring in ICD patients and how are they managed?
Are there combination therapies or alternative monitoring systems that enhance heart failure decompensation prediction?